Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J.V. McMurray, Anna-Maria Langkilde, Pham Nguyễn Vinh et al.|New England Journal of Medicine|2019Cited by 6.8k
Myocardial Viability and Survival in Ischemic Left Ventricular DysfunctionRobert O. Bonow, Julio A. Panza, Gerald Maurer et al.|New England Journal of Medicine|2011Cited by 877
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across RegionsMaría G. Crespo‐Leiro, Alexandre Mebazaa, Stefan D. Anker et al.|European Journal of Heart Failure|2016Cited by 781
In-Hospital and 1-Year Mortality Associated with Diabetes in Patients with Acute Heart Failure: Results from the ESC-HFA Heart Failure Long-Term RegistryGiovanni Targher, Marco Dauriz, Cécile Laroche et al.|European Journal of Heart Failure|2016Cited by 171
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the <scp>ESC‐HFA EORP</scp> Heart Failure Long‐Term RegistryAgnieszka Kapłon‐Cieślicka, Lars H. Lund, Lina Benson et al.|European Journal of Heart Failure|2021Cited by 127